Altachlore Sodium Chloride Hypertonicitysodium

70,394 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Altachlore Sodium Chloride Hypertonicity in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Altachlore Sodium Chloride Hypertonicity adverse event reports by reporter sex
SexReports
Female37,383
Male26,602
Unknown69

By Age Group

View age group data as a table
Altachlore Sodium Chloride Hypertonicity adverse event reports by reporter age group
Age groupReports
0-175,351
18-345,709
35-497,898
50-6413,693
65-749,917
75+7,094

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Altachlore Sodium Chloride Hypertonicity. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Altachlore Sodium Chloride Hypertonicity adverse event reports by reported outcome
OutcomeReports
Other Serious36,132
Hospitalization32,091
Non-Serious13,564
Death6,171
Life-Threatening4,786
Disability1,623

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Altachlore Sodium Chloride Hypertonicity. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Altachlore Sodium Chloride Hypertonicity adverse event reports by year
YearReports
19981
19991
20011
2004118
2005183
2006273
2007249
2008265
2009413
2010400
2011584
2012850
2013690
20141,147
20152,147
20163,096
20172,484
20183,594
20195,073
20206,379
20215,731
20227,387
20237,767
20249,493
20259,820
2026 (partial)2,248

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Altachlore Sodium Chloride Hypertonicity

In FDA adverse event reports that mention Altachlore Sodium Chloride Hypertonicity, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026